21. P87 The Impact of Respiratory Viruses and Pulmonary Exacerbations on FEV1 Decline in Adults with Cystic Fibrosis. (19th November 2012) Authors: Flight, WG; Mutton, KJ; Webb, AK; Bright-Thomas, RJ; Jones, AM Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. P88 Is Hydrogen Cyanide a Marker of Burkholderia Cepacia Complex Infection?. (19th November 2012) Authors: Gilchrist, FJ; Simms, H; Alcock, A; Jones, AM; Smith, D; Spanel, P; Webb, AK; Lenney, W Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. P91 Trypsin-like protease activity predicts disease severity and patient mortality in adults with cystic fibrosis. (15th November 2016) Authors: Reihill, JA; Moffitt, KL; Jones, AM; Elborn, JS; Martin, SL Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. P97 Gastro-oesophageal reflux in cystic fibrosis. (15th November 2016) Authors: Lord, RW; Pearson, JS; Barry, PJ; Whorwell, PJ; Jones, RB; McNamara, P; Beynon, R; Smith, JA; Jones, AM Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. PWE-110 Gastro-oesophageal reflux in cystic fibrosis: exploring the impact on lung disease. (17th June 2017) Authors: Lord, RW; Pearson, JS; Barry, PJ; Whorwell, PJ; Jones, RB; McNamara, PS; Beynon, R; Jones, AM; Smith, JA Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. S102 The effect of respiratory viruses on the lung microbiome of adults with cystic fibrosis. (14th November 2013) Authors: Flight, WG; Marchesi, JR; Smith, A; Norville, P; Mutton, KJ; Webb, AK; Bright-Thomas, RJ; Jones, AM; Mahenthiralingam, E Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. S137 Understanding the mechanisms for the increased prevalence of gastro-oesophageal reflux in cystic fibrosis. (December 2018) Authors: Lord, RW; Casey, J; Houghton, LA; Treadway, S; Jones, R; Barry, PJ; Whorwell, PJ; Smith, JA; Jones, AM Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. S16 The influence of the CFTR modulator ivacaftor on aspergillosis in cystic fibrosis. (12th November 2019) Authors: Fritsch, NC; Green, HD; Jones, AM; Barry, PJ Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. S18 The sputum proteome and its relationship to cystic fibrosis lung disease: using global proteomics to develop clinically useful biomarkers. (12th November 2019) Authors: Lord, RW; Maher, RE; Harman, V; Bianco, B; Whorwell, PJ; McNamara, PS; Smith, JA; Beynon, RJ; Jones, AM Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. S26 Untargeted sputum proteomics reveals anti-inflammatory effects of CFTR modulation. (11th November 2022) Authors: Maher, RE; Barrett, E; Barry, PJ; Emmott, E; Jones, AM; McNamara, PS; Smith, JA; Tewksbury, D; Lord, RW Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗